Results

Total Results: 81 records

Showing results for "end stage renal".

21. Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/yzXkWEQV3pn95yd_pmXZXk
    December 15, 2020 - hepatitis B are unaware of their infection,3 and many remain asymptomatic until onset of cirrhosis or end-stage … HBV-infected persons are unaware of their infection, and many remain asymptomatic until onset of cirrhosis or end-stage … Most studies ad- justed for patient age, sex, and stage of fibrosis; some also adjusted for level of … trials; RR, 0.92 [95% CI, 0.45-1.85]), any adverse event (5 trials; RR, 1.01 [95% CI, 0.90-1.11]), renal … therapies (including recently approved tenofovir alafenamide) on long- term health outcomes of cirrhosis, end-stage

22. ahrq12a_Summary_HBP.qxd (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
    January 01, 2010 - Additionally, they have an increased risk for end-stage renal disease, retinopathy, and aortic aneurysm … The Joint National Committee on Hypertension defined stage 1 hypertension as blood pressures ranging … from 140 to 159 systolic or 90 to 99 diastolic, stage 2 as pressures ranging from 160 to 179 systolic … Pharmacological Treatments for Adults with Hypertension Stage 3 Hypertension. … Stage 1 and Stage 2 Hypertension.

23. ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
    March 01, 2004 - We excluded studies of pregnant patients; children; and patients with occupational exposures, end-stage … Clinical outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular … We excluded studies that focused only on patients with end-stage liver disease, cirrhosis, or hepatocellular … undergone transplantation were excluded, as were studies of pregnant patients, children, or those with end-stage … renal disease or HIV infection.

24. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
    March 08, 2004 - We excluded studies of pregnant patients; children; and patients with occupational exposures, end-stage … Clinical outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular … We excluded studies that focused only on patients with end-stage liver disease, cirrhosis, or hepatocellular … undergone transplantation were excluded, as were studies of pregnant patients, children, or those with end-stage … renal disease or HIV infection.

25. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
    October 07, 2011 - What are the harms of treatment of early-stage or screening-detected prostate cancer? … Surveillance, Epidemiology, and End Results (SEER) program ( n =25,900) of men 65 to 80 years of age … comorbid conditions (diabetes, cardiovascular disease, respiratory disease, gastrointestinal disease, renal … 1: 29%  Stage 2: 40%  Stage 3: 31%  PSA < 10 µg/L: 22% PSA 11–29 µg/L: 28% PSA > 30 µg/L: 23% PSA unknown … prostate-specific antigen; RCT = randomized, controlled trial; SEER = Surveillance, Epidemiology, and End

26. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
    December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

27. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
    December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

28. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
    March 01, 2007 - At each screening stage, 2 members of the review team selected articles for inclusion after an initial … We sought existing systematic reviews to address the gastrointestinal, cardiovascular, and renal harms … The risks for hypertension and renal toxicity may also be elevated with COX-2 inhibitors and are reported … Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized … use; ASA, �162.5 mg/d or 325 mg every 2 days; FAP; HNPCC; IBD; invasive cancer; colonic resection; renal

29. Final Recommendation Statement: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/hepatitis-b-virus-infection-screening
    December 15, 2020 - hepatitis B are unaware of their infection, 3 and many remain asymptomatic until onset of cirrhosis or end-stage … Most studies adjusted for patient age, sex, and stage of fibrosis; some also adjusted for level of HBV … trials; RR, 0.92 [95% CI, 0.45-1.85]), any adverse event (5 trials; RR, 1.01 [95% CI, 0.90-1.11]), renal … therapies (including recently approved tenofovir alafenamide) on long-term health outcomes of cirrhosis, end-stage

30. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - At each screening stage, 2 members of the review team selected articles for inclusion after an initial … We sought existing systematic reviews to address the gastrointestinal, cardiovascular, and renal harms … The risks for hypertension and renal toxicity may also be elevated with COX-2 inhibitors and are reported … use; ASA, .162.5 mg/d or 325 mg every 2 days; FAP; HNPCC; IBD; invasive cancer; colonic resection; renal … Notes: a ASA = acetylsalicylic acid; BID = twice daily; COX-2 = cyclooxygenase-2; CRF = chronic renal

31. Recommendation: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening
    December 15, 2020 - hepatitis B are unaware of their infection, 3 and many remain asymptomatic until onset of cirrhosis or end-stage … Most studies adjusted for patient age, sex, and stage of fibrosis; some also adjusted for level of HBV … trials; RR, 0.92 [95% CI, 0.45-1.85]), any adverse event (5 trials; RR, 1.01 [95% CI, 0.90-1.11]), renal … therapies (including recently approved tenofovir alafenamide) on long-term health outcomes of cirrhosis, end-stage

32. Final Recommendation Statement: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/asymptomatic-bacteriuria-in-adults-screening
    September 24, 2019 - It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage … renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized … Subclinical renal infection and prematurity. Med J Aust . 1969;2(12):596-600. 21. 

33. Recommendation: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-bacteriuria-in-adults-screening
    September 24, 2019 - It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage … renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized … Subclinical renal infection and prematurity. Med J Aust . 1969;2(12):596-600. 21. 

34. Archived: Final Evidence Summary: Vitamin D and Calcium to Prevent Fractures: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
    December 10, 2011 - One RCT showed adverse outcomes associated with supplementation, including increased risk for renal and … We recorded whether the cancer or fracture outcomes were primary or secondary end points in the original … Cancer outcomes were secondary end points in all 3 RCTs. … Fracture outcomes were primary end points in 13 (81%) of the 16 RCTs. … Others have suspected that the adverse outcomes of renal and urinary stones were associated with excess

35. Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/6L2obA88s86MoZDbWtMPTU
    December 01, 2011 - One RCT showed adverse outcomes associated with supplementa- tion, including increased risk for renal … Ann Intern Med. 2011;155:827-838. www.annals.org For author affiliations, see end of text. … We recorded whether the cancer or fracture out- comes were primary or secondary end points in the original … Cancer out- comes were secondary end points in all 3 RCTs. … Fracture outcomes were pri- mary end points in 13 (81%) of the 16 RCTs.

36. Archived: Breast Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-january-2016
    January 11, 2016 - include (but are not limited to) AIDS, chronic obstructive pulmonary disease, liver disease, chronic renal … Information about morbidity or mortality end points is not available, so whether these women ultimately … the 19% estimate derived from the trials that did not have screening in their control groups at the end … Based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) … Based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER)

37. Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3R9N4ojm9Sk7qk8ybD3LU6
    October 11, 2019 - It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage … renal dis- ease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized … Subclinical renal infection and prematurity. Med J Aust. 1969;2(12):596-600. 21.

38. Evidence Summary: Hypertension in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertension-in-adults-screening
    April 27, 2021 - mortality, cardiovascular disease events, symptomatic peripheral artery disease, vascular dementia, end-stage … renal disease, and quality of life. … Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic … BP indicates blood pressure; CVD, cardiovascular disease; ESRD, end-stage renal disease; PAD, peripheral

39. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pth_4-Mnau_pZubaefDvUk
    January 01, 2020 - Ann Intern Med. 2016;164:279-296. doi:10.7326/M15-2886 www.annals.org For author affiliation, see end … Based on data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) … include (but are not limited to) AIDS, chronic obstructive pulmonary disease, liver disease, chronic renal … Information about morbid- ity or mortality end points is not available, so whether these women ultimately … the 19% estimate de- rived from the trials that did not have screening in their control groups at the end

40. Archived: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
    October 26, 2015 - cardiovascular mortality and morbidity and may also result in other complications, such as vision loss, renal … Diabetes is the leading cause of kidney failure, accounting for more than 44% of new cases of end-stage … renal disease in 2011. … Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose